Impact of Nurse-led Programme With Carotid Ultrasound on Addressing Cardiovascular Risk in Patients With Arthritis
Status:
Withdrawn
Trial end date:
2020-09-30
Target enrollment:
Participant gender:
Summary
Elevated CVD risk is a significant public health problem that contributes greatly to the
increased morbidity and shortened lifespan of individuals with RA and PsA. Over the past
decades, there has been great progress into the understanding of the severity of CVD risk in
these patients but these risk factors are not well managed. The development of the high-risk
strategy is therefore necessary, with more intensive therapy reserved for patients identified
as high-risk, e.g. because they have high-risk FRS. However, these risk scores
under-estimated CV risk in patients with RA and PsA. An intermediate approach is to use
quantification of preclinical vascular disease to further identify high-risk patients.
Results from this study will provide clinical implications in terms of detecting and managing
cardiovascular morbidity in patients with RA and PsA.